Estefanía Pérez‐López

Author

Instituto de Investigación Biomédica de Salamanca

Also Known As

E Perez-Lopez, E Pérez-López, E. Perez-Lopez, E. Perez‐Lopez, E. Pérez-López, E. Pérez‐López, Estefania Perez-Lopez, Estefania Pérez-López, Estefanía Pérez-López, Estefanía Perez-Lopez

Publications

294

Citations

H-Index

Concepts

All Affiliations

Instituto de Investigación Biomédica de Salamanca Universidad de Salamanca Centro de Investigación del Cáncer Hospital Universitario Central de Asturias

About

Estefanía Pérez‐López is an author at Instituto de Investigación Biomédica de Salamanca specializing in medicine, cell transplantation, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	215
2	Health Sciences	2	2	85
3	Public Health	1	1	86
4	Blood Transplantation	1	1	86
5	Cellular Therapies	1	1	51

Estefanía Pérez‐López

Publications

241

Citations

H-Index

Page 1

	Year	Citations
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients Jorge Labrador, Lucía López‐Anglada, Estefanía Pérez‐López, Haematologica Significant Clinical BleedingThrombosisVenous ThrombosisBlood TransfusionStem Cell Transplantation	2012	86
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus Jorge Labrador, Lucía López‐Corral, Oriana López‐Godino, Bone Marrow Transplantation ThrombopoiesisThrombosisCell TherapyVenous ThrombosisCardiovascular Disease	2014	51
ESHAP as salvage therapy for relapsed or refractory Hodgkin’s lymphoma Jorge Labrador, Mónica Cabrero, Estefanía Pérez‐López, Annals of Hematology Refractory Hodgkin ’Lymphoid NeoplasiaSurgical OncologyEsophageal CancerMedicine	2014	44
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia María‐Belén Vídriales, Estefanía Pérez‐López, Carlota Pegenaute, Leukemia Research Hematological MalignancyFlow CytometryComplementary ToolMedicineMixed-phenotype Acute Leukemia	2015	34
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial Mónica Cabrero, Alejandro Martı́n, Javier Briones, Biology of Blood and Marrow Transplantation	2016	15
Diagnostic utility of bone marrow examination for the assessment of patients with fever of unknown origin: a 10‐year single‐centre experience Jorge Labrador, Estefanía Pérez‐López, Mónica Cabrero, Internal Medicine Journal	2014	11

Page 1